1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Teriflunomide
Trade Name:
Aubagio
Manufacturer/Distributor:
Genzyme Canada
www.genzyme.ca
1-877-220-8918
Classification:
Immunomodulator agent
ATC Class:
L04AA - Selective immunosuppressants
Status:
active
Notice of Compliance (yyyy/mm/dd):
2013/11/14
Date Marketed in Canada (yyyy/mm/dd):
2013/11/15
Presentation:
Tablet: 14 mg. DIN: 02416328
Comments:
Teriflunomide is indicated as monotherapy for the treatment of patients with relapsing remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability. It should only be prescribed by clinicians who are experienced in the diagnosis and management of multiple sclerosis.
Source:
Product monograph
Back to:
Drug Product Listings 
